Profile
Dr. Michael Häggman is an Independent Director at Prostatype Genomics AB, an Associate Professor-Urology at Uppsala University Hospital, a Deputy Director at Kardinaltalet AB and a General Partner at Skrotum Kommanditbolag.
He is on the Board of Directors at Prostatype Genomics AB and Chundsell Medicals AB.
Michael Häggman active positions
| Companies | Position | Start |
|---|---|---|
| PROSTATYPE GENOMICS AB | Director/Board Member | 2017-12-31 |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Director/Board Member | - |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Corporate Officer/Principal | - |
Skrotum Kommanditbolag | Corporate Officer/Principal | - |
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Health Services |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Health Technology |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Prostatype Genomics AB
Prostatype Genomics AB Medical SpecialtiesHealth Technology Develops, manufactures and markets prognostic genetic test prostatype equipment | Health Technology |
Skrotum Kommanditbolag |
- Stock Market
- Insiders
- Michael Häggman
















